Sanofi Consumer Healthcare
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
Sanofi Consumer Healthcare's recent management commentary highlights a stable revenue growth trajectory, supported by improving margins and a conservatively financed balance sheet. The company's focus on high-return products aligns with the broader industry trend of increasing pricing power and demand for innovative therapies. Vista's financial outlook anticipates continued revenue growth consistent with historical performance, alongside margin improvements driven by operational efficiencies. The favorable macroeconomic environment in India, characterized by contained inflation and strong liquidity, further supports this outlook. However, potential headwinds include rising input costs and competitive pressures from established players in the fragmented market. Over the next 12-24 months, key opportunities lie in leveraging the growing demand for biosimilars and innovative products, while watchpoints include maintaining margin stability amidst cost fluctuations and navigating the competitive landscape. Overall, Sanofi Consumer Healthcare is well-positioned for growth, with a target price reflecting a modest upside, reinforcing Vista's positive investment stance
Why We Like This Stock
- Management's focus on high-return products enhances revenue growth potential
- Improving pricing power in the industry supports margin expansion
- A conservatively financed balance sheet provides financial stability
Things To Watch Out For
- Rising input costs may pressure margins in the near term
- Intense competition in the fragmented market could impact market share
- Potential currency fluctuations may affect export opportunities
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 555 | 724 | 878 | 938 | 1,062 |
| Profit Before Tax (Cr.) | 247 | 240 | 313 | 361 | 401 |
| PBT Margin | 44.6% | 33.2% | 3569.5% | 38.5% | 37.8% |
| Net Profit (Cr.) | 185 | 172 | 233 | 269 | 299 |
| Earnings Per Share | 80.4 | 74.9 | 101.4 | 116.8 | 129.8 |
Analyst Recommendations
No analyst recommendations available.
Company Overview
Show Company Profile
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. The company offers products in the allergy, physical wellness, and pain care segments under Allegra, Combiflam, Avil, DePURA, Festal, and other brand names through distributors, wholesalers, government institutions and hospitals, pharmacy chains, and e-commerce platforms. The company was incorporated in 2023 and is based in Mumbai, India. Sanofi Consumer Healthcare India Limited operates as a subsidiary of Opella Healthcare Participations B.V.